Paul Ranson LLB

Paul Ranson is a consultant who focuses on the regulatory and commercial needs of the pharmaceutical, biotechnology, and medical devices sectors. Paul’s regulatory expertise covers both marketing authorisation-related matters and market access, pricing, and reimbursement issues. His commercial work is concentrated on transactions with a high degree of industry specificity including collaborations and outsourcing transactions.

Paul spent the early part of his career in in-house roles with Smith Kline, Merck Sharp, and Dohme, and has subsequently maintained this industry focus. Paul is the legal adviser to the UK trade association for smaller and medium-sized companies (Ethical Medicines Industry Group) and the principal author of the legal module of an MSc on pharmaceutical licensing. He has also been a non-executive director of a specialty pharmaceutical company for some 10 years and was a member of an independent ethics committee for some 5 years.